Original
Factores pronósticos de eficacia y seguridad que afectan a la supervivencia global de los pacientes con cáncer de próstata metastásico sometidos a tratamiento con [177Lu]Lu-PSMA-617: estudio en un único centro
Efficacy, safety and prognostic factors affecting overall survival among metastatic prostate cancer patients undergoing treatment with 177Lu-PSMA-617: A single center study
S. Zarehparvar Moghadam, E. Askari, G. Divband, S. Shakeri, K. Aryana
Autor para correspondencia
Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Irán
Leído
280
Vecesse ha leído el artículo
74
Total PDF
206
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 8 | 1 | 2 | 3 |
| 2025 6 | 1 | 2 | 3 |
| 2025 2 | 5 | 4 | 9 |
| 2024 12 | 4 | 2 | 6 |
| 2024 11 | 1 | 1 | 2 |
| 2024 9 | 1 | 0 | 1 |
| 2024 7 | 1 | 1 | 2 |
| 2024 6 | 3 | 0 | 3 |
| 2024 5 | 4 | 0 | 4 |
| 2024 1 | 2 | 4 | 6 |
| 2023 12 | 2 | 2 | 4 |
| 2023 11 | 1 | 0 | 1 |
| 2023 10 | 3 | 0 | 3 |
| 2023 8 | 3 | 0 | 3 |
| 2023 5 | 2 | 2 | 4 |
| 2023 4 | 1 | 3 | 4 |
| 2023 3 | 5 | 5 | 10 |
| 2023 2 | 0 | 2 | 2 |
| 2022 1 | 1 | 0 | 1 |
| 2022 12 | 3 | 2 | 5 |
| 2022 11 | 1 | 2 | 3 |
| 2022 10 | 4 | 4 | 8 |
| 2022 9 | 5 | 8 | 13 |
| 2022 8 | 43 | 8 | 51 |
| 2022 7 | 99 | 10 | 109 |
| 2022 6 | 10 | 10 | 20 |
Mostrar todo
